What Hologic’s recent performance could mean for investors Hologic (HOLX) has been drawing fresh attention after a mix of modest short term moves and stronger past 3 months returns, prompting ...

HOLX nears its 52-week high on diagnostics growth and AI adoption, while tariffs and challenges in China continue to pose risks.

Fintel reports that on January 5, 2026, Evercore ISI Group downgraded their outlook for Hologic (NasdaqGS:HOLX) from ...

Between 2016 and 2019, researchers at a top-tier medical facility conducted 7,500 digital breast tomosynthesis (3D ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

In the fourth quarter of fiscal 2025, Diagnostics revenues increased 1.5% in constant currency (CC), driven by higher core ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...

Marlborough medical device manufacturer Hologic is anticipating to make an unspecified number of layoffs at international locations this year amid a restructuring of its diagnostics division, as sales ...

Powerful artificial intelligence combined with digital imaging designed to transform screening Genius™ Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 ...

The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid increase ...